[1]
N. A. Jassim, “Predictors of Response to (Etanercept) in the Treatment of Iraqi Patients with Active Rheumatoid Arthritis”, JFacMedBagdad, vol. 57, no. 1, pp. 35–39, Apr. 2015, doi: 10.32007/jfacmedbagdad.571304.